Differences of Modality Use between Telepractice and Face-to-Face Administration of the Scenario-Test in Persons with Dementia-Related Speech Disorder.
Mirjam GauchSabine CorstenKatharina GeschkeIsabel HeinrichJuliane LeinweberBianca SpelterPublished in: Brain sciences (2023)
Telepractice is increasingly finding its way into the care of people with dementia. Web-based delivery of speech and language therapy (SLT) is feasible and has the potential to improve communication in people with dementia-related speech disorders. Although experts are discussing the strengths and weaknesses of telepractice, a precise analysis of the differences between analogue and digital communication for this heterogeneous group of patients is still missing. The three current single cases investigated verbal and nonverbal aspects of communication in a face-to-face (F2F) and digital setting through a qualitative research design. Using the scenario-test (ST) in person and via big blue button (BBB; video conferencing system), several decisive factors were detected, influencing the effectiveness of communication in a F2F compared to a digital setting. The most important results of the qualitative content analysis are described for each case individually. Additionally, the influence of person-related factors, such as age, diagnosis, presence of depression, and level of education, is presented. Perceptual, executive, and affective disorders, as well as aids of relatives, are considered separately. The results indicate that executive functions, affects, and perceptual deficits need to be taken into account if telepractice is to be applied. Age, education, and distinct forms of dementia might be decisive for successful telepractice as well.
Keyphrases
- working memory
- healthcare
- mild cognitive impairment
- quality improvement
- end stage renal disease
- systematic review
- ejection fraction
- chronic kidney disease
- newly diagnosed
- randomized controlled trial
- traumatic brain injury
- palliative care
- prognostic factors
- cognitive impairment
- blood brain barrier
- depressive symptoms
- bipolar disorder
- hearing loss
- risk assessment
- stem cells
- physical activity
- patient reported outcomes
- sleep quality
- atomic force microscopy
- antiretroviral therapy
- mesenchymal stem cells
- single molecule
- drug induced
- artificial intelligence
- health insurance